Infectious Disease Advisor

Risk Score Demonstrates Strong Predictive Ability in Hematogenous Spinal Osteomyelitis

Poster findings presented at AAPM PainConnect 2026 showed that age, comorbidities, and preantibiotic use predicted outcomes in hematogenous spinal osteomyelitis.
JSTOR Daily

Treatment Of Acute Osteomyelitis

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...
Seeking Alpha

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

The Company will host a conference call and webcast today at 9:00 AM ET, followed by a Key Opinion Leader (KOL) event on April 3, 2025, at 11:00 AM ET to discuss the results "We believe these data ...
The New England Journal of Medicine

Chronic Alveolar Osteomyelitis (Pyorrhea Alveolaris): Its Causes and Treatment with Vaccines — With a Bacteriological Study and Report of One Hundred Fifteen Cases

BOSTON, Late Instructor in Pathology and Bacteriology, Tufts College Medical and Dental Schools; Pathologist and Visiting Physician for Vaccine Therapy, Mount Sinai Hospital, Boston. Copying failed.